RWM seeks daily investment results, before fees and expenses, that correspond to the inverse (-1x) of the daily performance of the Russell 2000 Index. The Russell 2000 is a float-adjusted, market-capitalization-weighted benchmark of roughly 2,000 of the smallest publicly traded U.S. companies within the broader Russell 3000, representing approximately 10% of that index's total market value.
The fund pursues its objective using derivatives rather than direct short positions in individual stocks. Its holdings are concentrated in U.S. Treasury bills, the ProShares GENIUS Money Market ETF, and a series of Russell 2000 total-return swaps with major counterparties, alongside short exposure through E-mini Russell 2000 futures. This structure delivers the inverse daily return while the cash and fixed-income collateral generate income that supports the fund's quarterly distributions.
RWM is a non-diversified, passively managed inverse fund with a net expense ratio of 0.95% and assets under management (AUM) of roughly $140 million to $165 million. It has traded since January 2007 and carries a negative beta relative to the S&P 500, meaning its price generally moves opposite to the broader large-cap market as well as to small-cap benchmarks. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the industry.
The environment facing RWM is defined by the health of U.S. small-cap equities and the macroeconomic forces that shape them. Small-cap companies are structurally more sensitive to interest rates than their large-cap peers, because they rely more heavily on floating-rate debt, bank lending, and external financing. As a result, shifts in monetary policy, inflation trends, and regional-bank credit conditions tend to transmit quickly into small-cap performance.
The Russell 2000 maintains meaningful weightings in financials, industrials, healthcare and biotechnology, technology, and consumer cyclical sectors. Many of these areas are highly cyclical and respond to growth expectations and financing costs. When small-cap leadership broadens and risk appetite improves, RWM tends to decline as its underlying benchmark advances; when small-cap valuations compress, the inverse structure can generate gains.
Beyond rates, investor positioning, equity-market breadth, and the concentration of returns in a small number of mega-cap technology names all influence the relative performance of the small-cap universe that RWM is designed to hedge.
Over the most recent 30-day period, RWM has been essentially range-bound, rising roughly 1% on an adjusted basis. That modest gain corresponds to a broadly flat-to-slightly-lower small-cap tape, with the inverse fund capturing little directional benefit as the Russell 2000 consolidated.
Over the last quarter, the picture is somewhat more pronounced: RWM has advanced about 6%, reflecting a period of relative small-cap softness. This move has not been a straight line. The fund has traded within a defined range, with bouts of volatility in both directions, consistent with its inverse daily-reset design and the sensitivity of the underlying index to shifting rate expectations and credit sentiment.
The fund's movement remains closely tied to the inverse of the Russell 2000 rather than to any single holding. Because its exposure is achieved through swaps and futures, the contributions of individual small-cap names are felt indirectly, through their aggregate effect on the index. Regional-bank performance, biotechnology share-price swings, and cyclical-sector rotation have been among the most visible influences on the index during the period.
The structural factors most likely to shape RWM during 2026 revolve around the path of monetary policy and the durability of the U.S. economic expansion. Because the fund's returns mirror the inverse of small-cap equities, a scenario of persistently restrictive interest rates or renewed inflation pressures could weigh on the Russell 2000 and support RWM, while a sustained easing cycle or improving credit conditions could pressure the fund.
Investors should monitor the earnings cycle across financials, industrials, healthcare, and consumer discretionary names, along with regional-bank lending conditions and small-cap access to capital. Breadth and sector rotation within the equity market, the relative valuation gap between large- and small-cap stocks, and institutional capital flows into and out of small-cap funds are additional variables to watch. Regulatory and tax-policy developments affecting smaller domestic companies may also influence the benchmark.
RWM is best understood as a short-term hedging instrument rather than a core long-term allocation, given its daily reset and the costs associated with maintaining inverse exposure over extended periods.
I often turn to Tickeron’s AI Screener when analyzing ETFs like this one. It lets me scan technical indicators, fundamentals, and AI signals across thousands of securities to quickly identify patterns or comparable vehicles. This platform has become a practical part of my workflow for refining ideas without replacing traditional analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active§ion=trades&via=john
RWM broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 42 similar instances where the stock broke above the upper band. In 38 of the 42 cases the stock fell afterwards. This puts the odds of success at 90%.
The 10-day RSI Indicator for RWM moved out of overbought territory on October 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 26 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.
The Momentum Indicator moved below the 0 level on October 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RWM as a result. In 78 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for RWM turned negative on October 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 37 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RWM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 64 cases where RWM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
Following a +1.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where RWM advanced for three days, in 227 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 174 of 215 cases where RWM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
Category Trading